Monoclonal antibody toxin conjugates for experimental graft-versus-host disease prophylaxis. Reagents selectively reactive with T cells and not murine stem cells.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Transplantation

• Publication date

  1983-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-198307000-00015PMID 6346616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.

  1982cited by this paper
• Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity

  1982cited by this paper
• Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate

  1982cited by this paper
• Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin

  1982cited by this paper
• Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.

  1982cited by this paper
• Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.

  1982cited by this paper
• Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients.

  1982cited by this paper
• Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.

  1981cited by this paper
• Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

  1981cited by this paper
• Cell-specific cytotoxicity expressed by a conjugate of ricin and murine monoclonal antibody directed against thy 1.1 antigen.

  1981cited by this paper
• BONE MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE EFFECT OF ELIMINATION OF T CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY‐1.2 PLUS COMPLEMENT OR ANTIBODY ALONE

  1981cited by this paper
• Studies on the galactose-binding site of ricin and the hybrid toxin Man6P-ricin.

  1981cited by this paper
• Successful bone-marrow transplantation for infantile malignant osteopetrosis.

  1980cited by this paper
• The kinetics of antibody binding to membrane antigens in solution and at the cell surface.

  1980cited by this paper
• Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia.

  1980cited by this paper
• Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.

  1980cited by this paper
• Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.

  1980cited by this paper
• Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

  1979cited by this paper
• Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens *

  1979cited by this paper
• Anti‐lymphocytic antibodies and marrow transplantation. III. Effect of heterologous anti‐brain antibodies on acute secondary disease in mice

  1974cited by this paper
• MODIFICATION OF SEVERE GRAFT‐VERSUS‐HOST DISEASE WITH ANTISERA TO THE &thetas; ANTIGEN OR TO WHOLE SERUM

  1973cited by this paper
• Treatment of abrin and ricin with β‐mercaptoethanol. Opposite effects on their toxicity in mice and their ability to inhibit protein synthesis in a cell‐free system

  1972cited by this paper
• Cellular immunology and the pathogenesis of graft versus host reactions.

  1971cited by this paper

• donor graft preincubation with anti-LFA1 immunotoxin alloengraftment across the major histocompatibility barrier after Prevention of murine graft-versus-host disease and bone marrow

  2011cites this paper
• Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling

  2003cites this paper
• Current status of ribosome inactivating proteins.

  2000cites this paper
• Immunotoxins for the therapy of graft versus host disease.

  1993cites this paper
• Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific anti-interleukin-2 receptor Bk chain immunotoxin.

  1993cites this paper
• Ribosome-inactivating proteins from plants.

  1993cites this paper
• Functional depletion of T cells by vincristine and methylprednisolone as an in vitro model for the prevention of graft versus host disease.

  1992cites this paper
• Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.

  1992cites this paper
• Clinical Use of Immunotoxins

  1991cites this paper
• Immunobiology of bone marrow transplantation as treatment for hematologic malignancies.

  1991cites this paper
• Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin.

  1991cites this paper
• Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.

  1991cites this paper
• Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.

  1990cites this paper
• SPECIFIC ELIMINATION OF ALLOREACTIVE T CELLS BY AN ANTI‐INTERLEUKIN-2 RECEPTOR B CHAIN‐SPECIFIC IMMUNOTOXIN

  1990cites this paper
• Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: Elimination of graft-versus-host disease without detrimental effects on engraftment

  1990cites this paper
• Ex vivo manipulation of bone marrow grafts with monoclonal antibodies

  1989cites this paper
• Monoclonal Antibodies

  1989cites this paper
• The effects of aromatic and aliphatic maleimide crosslinkers on anti-CD5 ricin immunotoxins.

  1989cites this paper
• Neuraminidase pretreatment of donor lymphocytes and graft-versus-host disease.

  1989cites this paper
• Immunotoxins: selection of cell-surface antigens and their corresponding monoclonal antibodies.

  1988cites this paper
• The effect of deoxycoformycin on bone marrow cells treated with adenosine and deoxyadenosine and hemopoietic growth factors.

  1988cites this paper
• T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.

  1988cites this paper
• ABSENCE OF A FACILITORY ROLE FOR NK 1.1‐POSITIVE DONOR CELLS IN ENGRAFTMENT ACROSS A MAJOR HISTOCOMPATIBILITY BARRIER IN MICE1,2

  1988cites this paper
• IMMUNOTOXINS FOR EX VIVO MARROW PURGING IN AUTOLOGOUS BONE MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOCYTIC LEUKEMIA

  1988cites this paper
• Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.

  1988cites this paper
• Combined immunochemotherapy of human solid tumors in nude mice.

  1987cites this paper
• MONOCLONAL ANTIBODY‐RICIN CONJUGATE CYTOTOXIC TO CELLS EXPRESSING THE COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN (CALLA)

  1987cites this paper
• RATIONALE FOR THE SELECTION OF RICIN A‐CHAIN ANTI‐T IMMUNOTOXINS FOR MATURE T CELL DEPLETION

  1987cites this paper
• An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia.

  1986cites this paper
• Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial.

  1986cites this paper
• [Autograft of bone marrow for the treatment of acute leukemia: in vitro efficacy of anti-leukemic purification].

  1986cites this paper
• Assessment of multi-organ system engraftment by genotypic typing using restriction fragment-length polymorphisms and by phenotypic typing using a microcytotoxicity assay.

  1986cites this paper
• Autologous bone marrow transplantation in acute leukemia.

  1986cites this paper
• Prevention of graft-versus-host disease in allogeneic bone marrow transplantation by pretreatment with 2'-deoxycoformycin.

  1986cites this paper
• Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent acute graft-versus-host disease. A pilot study in ten patients.

  1985cites this paper
• Preparation of antibody-toxin conjugates.

  1985cites this paper
• Post-transfusion graft-vs-host disease (GVHD): immunopathology and prevention.

  1985cites this paper
• Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.

  1985cites this paper
• A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.

  1985cites this paper
• ASSESSMENT OF IMMUNOCOMPETENCE BY LIMITING DILUTION ANALYSIS IN LONG‐TERM T CELL DEPLETION CHIMERAS TRANSPLANTED ACROSS THE MHC BARRIER

  1985cites this paper
• Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow.

  1985cites this paper
• Peptides and Proteins as Drugs

  1985cites this paper
• [16] Preparation of antibody—toxin conjugates

  1985cites this paper
• Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection.

  1985cites this paper
• Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.

  1985cites this paper
• MONOCLONAL ANTIBODY‐TOXIN CONJUGATES REACTIVE AGAINST HUMAN T LYMPHOCYTES: A COMPARISON OF ANTIBODY LINKED TO INTACT RICIN TOXIN WITH ANTIBODY LINKED TO RICIN A CHAIN

  1984cites this paper
• Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.

  1984cites this paper
• Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.

  1984cites this paper
• Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease.

  1984cites this paper
• Prevention and treatment of acute graft-versus-host disease.

  1984cites this paper
• Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.

  1984cites this paper
• Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies.

  1983cites this paper